Platform

mTIMED SLCT Platform

Metabolites derived from cellular metabolism modulates various cell functions in the respective microenvironments, especially in tumor and immune microenvironments. Excess accumulation or inadequate presence of these metabolites lead to various pathological conditions. Nirogy is focusing on metabolic SLCTs that are exposed to extracellular matrix (ECM) and employing these targets to build the integrated metabolic Tumor and Immune MicroEnvironment Drugs (mTIMED) platform as the discovery engine.

Our exploration begins with identifying a suitable target of interest and building homology models based on known structural data along with in-house mutational studies, and computational capabilities. Once reasonable model is established, we perform virtual screening of compound databases and available tool compounds while developing physiologically relevant proprietary biological assays to identify lead compounds. “Synchronous lead optimization strategy” provides us with rapid identification of few desired advanced leads to test in relevant in vivo mouse models. Translational bioinformatics is used to select relevant mouse models of target indication and mode of action (MOA). With a good understanding of MOA, disease modeling, and biomarkers, patient stratification driven clinical development will be conducted.

Nirogy Platform Transporter Biology

This website uses cookies to ensure you get the best experience on our website.

Vincent P. Sandanayaka, Ph.D.

FOUNDER

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga. Et harum quidem rerum facilis est et expedita distinctio. Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod maxime placeat facere possimus, omnis voluptas assumenda est, omnis dolor repellendus. Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet ut et voluptates repudiandae sint et molestiae non recusandae. Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut perferendis doloribus asperiores repellat